TransEnterix (Formerly Known as SafeStitch)

30 articles with TransEnterix (Formerly Known as SafeStitch)

• TransEnterix Announces New Training Center in EU

  2/18/2021

  Agreement with the Amsterdam Skills Centre Establishes Second European Surgical Training Site for Senhance Digital Laparoscopy

• TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million - Jan 27, 2021

  1/27/2021

  TransEnterix, Inc. announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of $3.00 per share, less underwriting discounts and commissions.

• TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020

  11/5/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced its operating and financial results for the third quarter of 2020.

• TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020

  10/26/2020

  TransEnterix, Inc. announced that it plans to release third quarter financial and operating results after the market closes on Thursday, November 5, 2020.

• TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities

  9/23/2020

  Intelligent Surgical Unit Enables Augmented Intelligence on the Senhance System

• TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System

  9/14/2020

  TransEnterix, Inc. announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International Medical Center in the Greater Tokyo Area.

• TransEnterix Announces Appointment of Shameze Rampertab as Chief Financial Officer

  8/13/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that Shameze Rampertab has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective August 24, 2020.

• TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System

  7/27/2020

  TransEnterix, Inc. announced that Maastricht University Medical Center+ has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first hospital to acquire a Senhance to be utilized in pediatric minimally invasive surgery.

• TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System

  6/23/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that the Sana Klinikum Offenbach has entered into an agreement to lease and utilize a Senhance® Surgical System.

• TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2020

  5/14/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced its operating and financial results for the first quarter of 2020.

• TransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2020

  5/5/2020

  TransEnterix, Inc. announced that it plans to release first quarter financial and operating results before the market opens on Thursday, May 14, 2020.

• TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2019

  3/16/2020

  TransEnterix, Inc. announced its operating and financial results for the fourth quarter and full-year 2019.

• TransEnterix Schedules Fourth Quarter and Fiscal Year 2019 Financial and Operating Results Conference Call for March 16, 2020

  3/9/2020

  TransEnterix, Inc. announced that it plans to release fourth quarter financial and Fiscal year 2019 operating results after the market closes on Monday, March 16, 2020.

• TransEnterix Announces Launch of Underwritten Public Offering - March 5, 2020

  3/5/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that it has commenced an underwritten offering of units.

• TransEnterix Announces Common Stock Purchase Agreement by Lincoln Park Capital Fund, LLC

  2/10/2020

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.

• TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2019

  11/12/2019

  TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced its operating and financial results for the third quarter of 2019 and provided a business update.

• TransEnterix Announces Plan for Reverse Stock Split

  10/30/2019

  Company’s action intended to increase the market price of its Common Stock in connection with its previously-announced pursuit of strategic alternatives

• TransEnterix Announces Pricing of Public Offering of Common Stock

  9/5/2019

  TransEnterix, Inc. announced that it priced a public offering of 28,000,000 shares of its common stock for gross proceeds of approximately $20.3 million, before deducting underwriting discounts and commissions and offering expenses payable by TransEnterix.

• TransEnterix to Present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference

  8/21/2019

  TransEnterix, Inc. announced that Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Wells Fargo Securities Research, Economics & Strategy 2019 Healthcare Conference in Boston, MA.

• TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2019

  8/7/2019

  TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2019.